Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya

Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya

<strong>Background:</strong> Maternal immunisation to boost respiratory syncytial virus (RSV) antibodies in pregnant women, is a strategy being considered to enhance infant protection from severe RSV associated disease. However, little is known about the efficiency of transplacental tran...

Full description

Bibliographic Details
Main Authors:	Nyiro, JU, Bukusi, E, Mwaengo, D, Nyaguara, A, Nyawanda, B, Otieno, N, Bigogo, G, Murunga, N, Widdowson, M-A, Verani, JR, Chaves, SS, Mwangudza, H, Odundo, C, Berkley, JA, Nokes, DJ, Munywoki, PK
Format:	Journal article
Language:	English
Published:	F1000Research 2022

Similar Items

Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya [version 2; peer review: 2 approved]
by: Amek Nyaguara, et al.
Published: (2022-04-01)

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
by: Nyiro, JU, et al.
Published: (2020)

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
by: Joyce U. Nyiro, et al.
Published: (2020-11-01)

Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries [version 1; peer review: 2 approved]
by: Alice Ouma, et al.
Published: (2023-04-01)

Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya
by: Nyiro, JU, et al.
Published: (2017)

Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010–2018
by: Bryan O. Nyawanda, et al.
Published: (2023-03-01)

Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021
by: Bryan O. Nyawanda, et al.
Published: (2023-06-01)

Absence of association between cord specific antibody levels and severe respiratory syncytial virus (RSV) disease in early infants: A case control study from coastal Kenya
by: Nyiro, J, et al.
Published: (2016)

Drivers of respiratory syncytial virus seasonal epidemics in children under 5 years in Kilifi, coastal Kenya.
by: James Wambua, et al.
Published: (2022-01-01)

Drivers of respiratory syncytial virus seasonal epidemics in children under 5 years in Kilifi, coastal Kenya
by: James Wambua, et al.
Published: (2022-01-01)

Spatio-temporal distribution of rhinovirus types in Kenya: a retrospective analysis, 2014
by: Morobe, JM, et al.
Published: (2024)

Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.
by: Joyce U Nyiro, et al.
Published: (2017-01-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
by: Samuel PC Brand, et al.
Published: (2020-03-01)

Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.
by: Joyce Uchi Nyiro, et al.
Published: (2016-01-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
by: Kinyanjui, T, et al.
Published: (2020)

Pathobiology of Respiratory Syncytial Virus (RSV)
by: Ralph A. Tripp, et al.
Published: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
by: Leonard R. Krilov, et al.
Published: (2022-09-01)

Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study [version 2; referees: 2 approved, 2 approved with reservations]
by: Miriam Wathuo, et al.
Published: (2017-03-01)

Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study [version 1; referees: 2 approved, 1 approved with reservations]
by: Miriam Wathuo, et al.
Published: (2016-12-01)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)
by: Mahikul, W, et al.
Published: (2019)

Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
by: Gideon O Emukule, et al.
Published: (2017-01-01)

Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis
by: Chee, Chris, et al.
Published: (2010-02-01)

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa
by: Mihaly Koltai, et al.
Published: (2023-03-01)

Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya
by: Nyiro, J, et al.
Published: (2019)

Genomic analysis of respiratory syncytial virus infections in households and utility in inferring who infects the infant
by: Agoti, CN, et al.
Published: (2019)

Transmission patterns and evolution of respiratory syncytial virus in a community outbreak identified by genomic analysis
by: Agoti, CN, et al.
Published: (2017)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
by: Wiriya Mahikul, et al.
Published: (2019-01-01)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
by: Dvir Gatt, et al.
Published: (2023-01-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
by: Rachel J Derscheid, et al.
Published: (2013-01-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
by: Anne M Hause, et al.
Published: (2017-01-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
by: Anne M Hause, et al.
Published: (2017-01-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
by: Mark R. Ackermann, et al.
Published: (2012-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
by: Shira Hirsh, et al.
Published: (2014-01-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
by: White, L, et al.
Published: (2005)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
by: Timothy Kinyanjui, et al.
Published: (2020-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
by: White, L, et al.
Published: (2005)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
by: Antepowicz, A, et al.
Published: (2018)